CNS SARCOIDOSIS

Clinical trials for CNS SARCOIDOSIS explained in plain language.

Never miss a new study

Get alerted when new CNS SARCOIDOSIS trials appear

Sign up with your email to follow new studies for CNS SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New gel therapy aims to calm brain inflammation without harsh steroid side effects

Disease control Completed

This study tested whether H.P. Acthar Gel can improve symptoms and quality of life in people with CNS sarcoidosis, a rare condition where inflammation affects the brain and spinal cord. Four adults with the disease received the gel to see if it could control disease activity and …

Matched conditions: CNS SARCOIDOSIS

Phase: PHASE4 • Sponsor: University of Maryland, Baltimore • Aim: Disease control

Last updated Jun 10, 2026 13:27 UTC

CNS SARCOIDOSIS

Get alerted when new CNS SARCOIDOSIS trials appear

New gel therapy aims to calm brain inflammation without harsh steroid side effects